REC-4881 is an orally bioavailable, non-ATP-competitive allosteric small molecule MEK 1/2 inhibitor. The platform analyzed cellular models of APC gene loss-the root cause of FAP-to identify compounds ...

Oral hormone therapy may benefit heart health in menopausal women. A new analysis of data from the Women's Health Initiative found that estrogen-based oral hormone therapy had a long-term beneficial ...

Sylvie Grégoire, Chair of Abivax Board of Directors, commented: “We are delighted to welcome Dominik to the Board at such a pivotal moment for Abivax. His extensive background in global medical ...

A proof-of-concept study will test VAS-101, a topical gel using the turmeric extract curcumin, in sickle cell disease (SCD) ...

Evidence-Based Psychological Practice (EBPP) is a global priority for improving mental health care. While Cognitive Behavioral Therapy (CBT) remains one of ...

Research from Harvard Forest identified a crucial relationship between precipitation patterns and soil types in New England.

Andrei Georgescu of Vivodyne discusses key advantages of its humanized drug testing platform and the impact of the FDA’s policy shift.

Visit https://www.apbioinc.com/en/ for more information about AP Biosciences and its pipeline of next-generation cancer therapies.

Neuroscientists have developed a new treatment approach for a language disorder that combines traditional speech therapy with noninvasive electrical stimulation of the brain. Brain stimulation helped ...

Ensem Therapeutics announces U.S. FDA IND clearance to start ETX-636 clinical trials. Also, ENSEM will present preclinical data at AACR meeting.

The clinical training part of medical school means you finally get to put all the book learning, lectures, laboratories, and ...

Blood pressure is known to be a risk factor for developing dementia. A study, published in the journal 'Neurology' in January ...